Al Shahrani M: Difference between revisions
From Bioblast
(Created page with "{{Person}}") |
No edit summary |
||
Line 1: | Line 1: | ||
{{Person}} | {{Person | ||
|lastname=Al-Sharani | |||
|firstname=Mesfer | |||
|institution=The National Hospital for Neurology & Neurosurgery | |||
Neurometabolic Unit | |||
|address=Queen Square | |||
|city=London | |||
|country=UK | |||
}} | |||
{{Labelingperson}} |
Revision as of 17:06, 21 January 2015
Name | Al-Sharani Mesfer, |
---|---|
Institution | The National Hospital for Neurology & Neurosurgery
Neurometabolic Unit |
Address | Queen Square, |
City | London |
State/Province | |
Country | UK |
[email protected] | |
Weblink | |
O2k-Network Lab | UK London Land JM |
Labels:
Publications
Published | Reference | |
---|---|---|
Hargreaves 2016 Drug Saf | 2016 | Hargreaves IP, Al Shahrani M, Wainwright L, Heales SJR (2016) Drug-induced mitochondrial toxicity. Drug Saf 39:661–74. https://doi.org/10.1007/s40264-016-0417-x. |